Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases.
Tumor necrosis factor alpha (TNFalpha) is involved in cell differentiation, mitogenesis, cytotoxic responses, inflammation, immunomodulation, and wound healing. Because of its numerous roles, it was thought that inhibition of TNF may aid in the treatment of certain dermatologic diseases such as psor...
| Publicado en: | Dermatology Nursing Vol. 17; no. 2; pp. 97 - 109 |
|---|---|
| Autores principales: | , |
| Formato: | CEU pictorial Journal Article |
| Publicado: |
Jannetti Publications, Inc.
Apr2005
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106639839&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106639839 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10603441 38V jtl: Dermatology Nursing issn: 10603441 maglogo: N pubinfo: dt: Apr2005 vid: 17 iid: 2 pid: 4135 pub: Jannetti Publications, Inc. place: Pitman, New Jersey artinfo: ui: 106639839 106639839 2005087094 NLM15916184 106639839 ppf: 97 ppct: 12 formats: fmt: @attributes: type: P tig: atl: Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases. aug: au: Trent JT Kerdel FA affil: Resident, Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami, FL sug: subj: Antibodies, Monoclonal Therapeutic Use Behcet's Syndrome Drug Therapy Hidradenitis Suppurativa Drug Therapy Psoriasis Drug Therapy Pyoderma Gangrenosum Drug Therapy Skin Diseases Drug Therapy Tumor Necrosis Factor Antagonists and Inhibitors Antibodies, Monoclonal Pharmacodynamics Behcet's Syndrome Immunology Behcet's Syndrome Physiopathology Clinical Trials Education, Continuing (Credit) Etanercept Administration and Dosage Etanercept Adverse Effects Etanercept Pharmacodynamics Graft Versus Host Disease Drug Therapy Graft Versus Host Disease Physiopathology Hidradenitis Suppurativa Complications Hidradenitis Suppurativa Physiopathology Immunotherapy Infliximab Administration and Dosage Infliximab Adverse Effects Infliximab Pharmacodynamics Psoriasis Immunology Psoriasis Physiopathology Pyoderma Gangrenosum Immunology Pyoderma Gangrenosum Physiopathology Treatment Outcomes ab: Tumor necrosis factor alpha (TNFalpha) is involved in cell differentiation, mitogenesis, cytotoxic responses, inflammation, immunomodulation, and wound healing. Because of its numerous roles, it was thought that inhibition of TNF may aid in the treatment of certain dermatologic diseases such as psoriasis, hidradentitis suppurativa, pyoderma gangrenosum, Behcet's syndrome, and graft versus host disease. The efficacy of these agents has proven impressive and short-term side effects have been few and relatively benign. pubtype: Academic Journal doctype: CEU pictorial Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|